The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Home

2017
Lv J, Zhang H, Wong MGeot, et al. Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. JAMA. 2017;318(5):432-442. doi:10.1001/jama.2017.9362.
Miller HM, Tong A, Tunnicliffe DJ, et al. Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units. Hemodial Int. 2017;21(2):213-223. doi:10.1111/hdi.12457.
Hackett M, Jardine M. We Need to Talk about Depression and Dialysis: but What Questions Should We Ask, and Does Anyone Know the Answers?. Clin J Am Soc Nephrol. 2017;12(2):222-224. doi:10.2215/CJN.13031216.
Jardine M, Zuo L, Gray NA, et al. A Trial of Extending Hemodialysis Hours and Quality of Life. J Am Soc Nephrol. 2017. doi:10.1681/ASN.2015111225.
Foote C, Woodward M, Jardine M. Scoring Risk Scores: Considerations Before Incorporating Clinical Risk Prediction Tools Into Your Practice. Am J Kidney Dis. 2017;69(5):555-557. doi:10.1053/j.ajkd.2017.02.005.
Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390(10105):1888-1917. doi:10.1016/S0140-6736(17)30788-2.
Miller HM, Tong A, Tunnicliffe DJ, et al. Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units. Hemodialysis International. 2017;21(2).
Heerspink HJ, Desai M, Jardine M, Balis D, Meininger G, Perkovic V. Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects. Journal of the American Society of Nephrology. 2017.
Wang A, Sherrington C, Toyama T, et al. Muscle strength, mobility, quality of life and falls in patients on maintenance haemodialysis: A prospective study. Nephrology (Carlton). 2017;22(3):220-7.
2016
Sukkar L, Hong D, Wong MG, et al. Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis. BMJ (Clinical Research Ed.). 2016;355:i5599.
Liyanage T, Ninomiya T, Wang A, et al. Effects of the Mediterranean Diet on Cardiovascular Outcomes-A Systematic Review and Meta-Analysis. PLoS OnePLoS ONEPLoS ONE. 2016;11:e0159252.
Chan KE, Giugliano RP, Patel MR, et al. Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF. Journal of the American College of Cardiology. 2016;67:2888-99.
Nigwekar SU, Kang A, Zoungas S, et al. Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Database of Systematic Reviews. 2016:CD004683.
Wang A, Ivany JN, Perkovic V, Gallagher M, M W, Jardine M. Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease. Cochrane Database of Systematic Reviews. 2016;4:CD009631.
Woodward M, Hirakawa Y, Kengne AP, et al. Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score. Diabetes, Obesity & Metabolism. 2016;18:289-94.
2015
Perkovic V, Jardine M, Vijapurkar U, Meininger G. Renal effects of canagliflozin in type 2 diabetes mellitus. Current Medical Research and Opinion. 2015;31:2219-31.
Jardine M, Perkovic V. First Light After the Long Night: A Follow-up Report of the Randomized FHN Nocturnal Trial. American Journal of Kidney Diseases. 2015;66:379-82.
Foote C, Kotwal S, Gallagher M, Cass A, Brown M, Jardine M. Survival Outcomes of Supportive Care versus Dialysis Therapies for Elderly Patients with End Stage Kidney Disease: a systematic review and meta-analysis. Nephrology (Carlton). 2015.
Wang A, Bellomo R, Cass A, et al. Health-related Quality of Life in Survivors of Acute Kidney Injury: the Post-RENAL Study Outcomes. Nephrology (Carlton). 2015;20:492-8.
Kang A, Nigwekar SU, Perkovic V, et al. Interventions for lowering plasma homocysteine levels in kidney transplant recipients. Cochrane Database of Systematic Reviews. 2015;5.
Jardine M, Zuo LI, Gray NA, et al. Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': the ACTIVE Dialysis Study. Nephrology (Carlton). 2015;20:257-65.
Jardine M. Lifestyle and dietary interventions in DKD. In: Kidney Disease - Improving Global Outcomes Conference . Kidney Disease - Improving Global Outcomes Conference . Vancouver, Canada; 2015.
Jardine M. Role of Antiplatelets in DKD. In: Kidney Disease - Improving Global Outcomes Conference . Kidney Disease - Improving Global Outcomes Conference . Vancouver, Canada; 2015.
Jardine M. Salt - friend or foe? The impact of salt reduction on chronic kidney disease [invited speaker]. In: 2015 Amgen One Scientific Symposium. 2015 Amgen One Scientific Symposium. Sydney, Australia; 2015.
2014
Foote C, Morton RL, Jardine M, et al. COnsiderations of Nephrologists when SuggestIng Dialysis in Elderly patients with Renal failure (CONSIDER): a discrete choice experiment. Nephrology, Dialysis, Transplantation. 2014;29:2302-9.

Pages